[ad_1] Revised transaction values Metsera at up to $86.25 per share Metsera’s Board of Directors unanimously recommends that Metsera stockholders approve the adoption of the amended Pfizer merger agreement and approve the merger with Pfizer Transaction […]

[ad_1] NEW YORK, Nov. 5, 2025 /PRNewswire/ — Metsera, Inc. (NASDAQ: MTSR) (“Metsera” or the “Company”) today issued the following statement in response to a ruling in the litigation filed against the Company by Pfizer: […]

[ad_1] NEW YORK, Oct. 31, 2025 /PRNewswire/ — Metsera, Inc. (NASDAQ: MTSR) (“Metsera” or the “Company”) today issued the following statement in response to litigation filed against the Company by Pfizer: “Metsera disagrees with the […]